Biblio Discovery — Demo Discovery Service

122 hasil untuk "Kohanbash, Gary"

Menampilkan 1–20 · 0,71 detik · RSS

  1. Artikel Jurnal Teks lengkap

    MicroRNAs and STAT Interplay

    Kohanbash, Gary; Okada, Hideho

    Semin Cancer Biol · 2011 · Inggris · PubMed Central

    MicroRNA (miR) are emerging as important gene expression regulators often involved in a variety of pathogenesis such as cancers and autoimmunity. Signal Transducers and Activators of Transcription (STAT) proteins are the principle signaling proteins for many cytokines and growth factors, thereby…

  2. Artikel Jurnal Teks lengkap

    MicroRNAs in Immune Regulation - Opportunities for Cancer Immunotherapy

    Okada, Hideho; Kohanbash, Gary; Lotze, Michael T.

    Int J Biochem Cell Biol · 2010 · Inggris · PubMed Central

    Endogenously produced microRNAs are predicted to regulate the translation of over two-thirds all human gene transcripts. Certain microRNAs regulate expression of genes that are critically involved in both innate and adaptive immune responses. Immune cells represent a highly attractive target for…

  3. Artikel Jurnal Teks lengkap

    EXTH-85. ASSESSMENT OF ANTI-CD69 ANTIBODY THERAPY ALONE OR IN COMBINATION WITH ANTI-PD-1 IN MURINE GBM

    Nisnboym Ziv, Michal; Kohanbash, Gary; Raphael, Itay

    Neuro Oncol · 2024 · Inggris · PubMed Central

    BACKGROUND: Glioblastoma multiforme (GBM) is an aggressive central nervous system malignancy with a dismal prognosis. There is continued interest in trying multiple immunotherapy modalities for this intractable cancer. Cluster of differentiation 69 (CD69), is an early marker of T and NK cell…

  4. Artikel Jurnal Teks lengkap

    NK cells link immune-checkpoint blockade immunotherapy and response in melanoma brain metastases

    Kohanbash, Gary; Frederico, Stephen C.; Raphael, Itay

    J Immunother Cancer · 2025 · Inggris · PubMed Central

    Melanoma brain metastases (BMs) pose a significant clinical challenge. This commentary highlights the emerging understanding of the mechanisms behind immune-checkpoint blockade (ICB) efficacy in melanoma BMs. Specifically, we focus on a recent study by Fife et al, which revealed a non-canonical…

  5. Artikel Jurnal Teks lengkap

    TMIC-34. Na/H EXCHANGER ISOFORM 1 (NHE1) IN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT IN MOUSE SYNGENEIC GLIOMA MODEL

    Hasan, Nabiul; Guan, Xiudong; Kohanbash, Gary dkk.

    Neuro Oncol · 2018 · Inggris · PubMed Central

    Glioblastoma is the most common and aggressive brain tumor with a median survival of ~15 months. Clinical trials of patients for immunotherapy showed an inferior response, which can in part attribute to an immunosuppressive, acidic tumor microenvironment (TME) composed of glioma-associated…

  6. Artikel Jurnal Teks lengkap

    ONO-AE3-208 inhibits myeloid derived suppressor cells and glioma growth

    Kohanbash, Gary; Straw, Erin; Ahn, Brian dkk.

    J Immunother Cancer · 2014 · Inggris · PubMed Central

  7. Artikel Jurnal Teks lengkap

    Pre-clinical models for evaluating glioma targeted immunotherapies

    Frederico, Stephen C.; Zhang, Xiaoran; Hu, Baoli dkk.

    Front Immunol · 2023 · Inggris · PubMed Central

    Gliomas have an extremely poor prognosis in both adult and pediatric patient populations as these tumors are known to grow aggressively and respond poorly to standard of care treatment. Currently, treatment for gliomas involves surgical resection followed by chemoradiation therapy. However, some…

  8. Artikel Jurnal Teks lengkap

    Transgene-derived overexpression of miR-17-92 in CD8(+) T-cells confers enhanced cytotoxic activity

    Kosaka, Akemi; Ohkuri, Takayuki; Ikeura, Maki dkk.

    Biochem Biophys Res Commun · 2015 · Inggris · PubMed Central

    MicroRNAs (miRs) play important roles in regulation of a variety of cell functions, including immune responses. We have previously demonstrated that miR-17-92 expression in T-cells enhances Th1 phenotype and provides a long-term protection against glioblastoma when co-expressed as a transgene in…

  9. Artikel Jurnal Teks lengkap

    TMIC-51. SEX-SPECIFIC T CELL BEHAVIOR DRIVES DIFFERENTIAL IMMUNE RESPONSES IN GLIOBLASTOMA

    Lee, Juyeun; Sneiderman, Chaim; Kohanbash, Gary dkk.

    Neuro Oncol · 2022 · Inggris · PubMed Central

    Glioblastoma (GBM) is the most common primary malignant brain tumor and shows poor outcomes as a median survival is 12-18 months with current standard-of-care of therapy. GBM exhibits sex differences in incidence and overall survival, with males experiencing a higher incidence and a worse prognosis…

  10. Artikel Jurnal Teks lengkap

    EXTH-42. GLIOMA-DERIVED CD200 PROMOTES TUMOR GROWTH AND SUPPRESSES NK CELL AND CD8 T CELL ANTI-GLIOMA ACTIVITY

    Raphael, Itay; Graner, Michael; Moertel, Christopher dkk.

    Neuro Oncol · 2024 · Inggris · PubMed Central

    Immune-checkpoint inhibitors, such as anti-PD1 and anti-CTLA4, have emerged as promising therapeutic options for several malignancies yet show little efficacy against malignant brain cancers. CD200 is a newly recognized immune-checkpoint which is expressed by a marid of cell types, modulating…

  11. Artikel Jurnal Teks lengkap

    IDH mutation-induced suppression of type-1 anti-glioma immune response

    Kohanbash, Gary; Shrivastav, Shruti; Ahn, Brian dkk.

    J Immunother Cancer · 2015 · Inggris · PubMed Central

  12. Artikel Jurnal Teks lengkap

    TMIC-39. DEVELOPMENT OF CD11b TRACER FOR THE IMMUNE PET IMAGING IN GLIOBLASTOMA MODEL - COULD BE A GAME CHANGER FOR IMMUNOTHERAPY APPROACHES

    Nigam, Shubhanchi; McCarl, Lauren; Kumar, Rajeev dkk.

    Neuro Oncol · 2019 · Inggris · PubMed Central

    Glioblastoma is a lethal brain tumor, heavily infiltrated by tumor-associated myeloid cells (TAMCs). As up to 30% of a glioma cellular mass may be attributed to immunosuppressive myeloid cells, including myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs). TAMCs impede…

  13. Artikel Jurnal Teks lengkap

    IMMU-06. Landscape of adaptive immunity of childhood brain cancers

    Raphael, Itay; Chikina, Maria; Broniscer, Alberto dkk.

    Neuro Oncol · 2022 · Inggris · PubMed Central

    T lymphocytes have a unique ability to recognize a vast array of antigens prompted by an enormous T cell receptor (TCR) repertoire. Characterization of tumor-infiltrating T cells (TILs) is key to understand MHC-restricted anti-tumor immunity and for developing T cell-centered immunotherapies such…

  14. Artikel Jurnal Teks lengkap

    Glioblastoma vaccines: past, present, and opportunities

    Xiong, Zujian; Raphael, Itay; Olin, Michael dkk.

    eBioMedicine · 2024 · Inggris · PubMed Central

    Glioblastoma (GBM) is one of the most lethal central nervous systems (CNS) tumours in adults. As supplements to standard of care (SOC), various immunotherapies improve the therapeutic effect in other cancers. Among them, tumour vaccines can serve as complementary monotherapy or boost the clinical…

  15. Artikel Jurnal Teks lengkap

    IMMU-16. GUADECITABINE (SGI-110) ENHANCES MHC class I AND TUMOR ANTIGEN EXPRESSION ON MURINE C57BL/6-SYNGENEIC GLIOMA AND DIPG MODELS

    Kohanbash, Gary; McCarl, Lauren; Shoger, Karsen dkk.

    Neuro Oncol · 2018 · Inggris · PubMed Central

    Diffuse intrinsic pontine glioma (DIPG) is one of the most lethal pediatric brain tumors, with a median survival time of less than one year. As DIPG tumors are insensitive to chemotherapy and surgically inaccessible, there is an urgent need for the development of novel therapeutic approaches. Our…

  16. Artikel Jurnal Teks lengkap

    TMIC-19. H(+) EXTRUSION PROTEIN NA/H EXCHANGER IN METABOLIC POLARIZATION OF GLIOMA-ASSOCIATED MICROGLIA/MACROPHAGES AND TUMOR IMMUNITY

    Nabiul Hasan, Md; Guan, Xiudong; Ahuja, Avani dkk.

    Neuro Oncol · 2019 · Inggris · PubMed Central

    Immunosuppressive tumor microenvironment (TME) in glioblastoma (GBM) attributes to poor efficacy of chemotherapy and/or immunotherapy. We recently reported that SLC9A1 gene expression (Na/H exchanger 1, NHE1) in GBM tumor correlates with increased macrophage tumor infiltration and worsened patient…

  17. Artikel Jurnal Teks lengkap

    Protocol to assess the antitumor efficacy of an immunotherapeutic peptide in syngeneic orthotopic glioma mouse models

    Chen, Apeng; Chao, Yapeng; Zou, Han dkk.

    STAR Protoc · 2023 · Inggris · PubMed Central

    Understanding the glioblastoma (GBM) immune microenvironment and development of clinical treatment drugs rely on suitable preclinical GBM models. Here, we present a protocol to establish syngeneic orthotopic glioma mouse models. We also describe the steps to intracranially deliver immunotherapeutic…

  18. Artikel Jurnal Teks lengkap

    Developing and Characterizing the Tumor-Targeting Efficiency of an Anti-EphA2-CD11b Bispecific Antibody

    Birikorang, Peggy A.; Menendez, Dominic M.; Edinger, Robert dkk.

    Bioconjug Chem · 2025 · Inggris · PubMed Central

    Targeting molecules, such as antibodies and peptides, play a key role in the precise delivery of cytotoxic payloads to tumor sites by binding to specific tumor-associated antigens or other proteins within the tumor microenvironment. This investigation evaluates the potential therapeutic application…

  19. Artikel Jurnal Teks lengkap

    IMMU-21. DEVELOPMENT OF PET TRACERS FOR NON-INVASIVE IMAGING OF IMMUNOTHERAPY IN DIFFUSE INTRINSIC PONTINE GLIOMA

    Nigam, Shubhanchi; McCarl, Lauren; Anderson, Carolyn dkk.

    Neuro Oncol · 2019 · Inggris · PubMed Central

    DIPG is an incurable brain tumor with median overall survival times of less than 10 months, with current treatment. Immunotherapy is an attractive approach for some DIPG patients based on promising clinical and preclinical studies. However, due to surgical inaccessibility, intratumoral…

  20. Artikel Jurnal Teks lengkap

    CSIG-01. NA-K-CL COTRANSPORTER PROTEIN IN THE PATHOGENESIS OF LOW-GRADE GLIOMAS

    Luo, Lanxin; Guan, Xiudong; Begum, Gulnaz dkk.

    Neuro Oncol · 2019 · Inggris · PubMed Central

    Low-grade gliomas (LGGs) present a high incidence of epilepsy, infiltrative growth, resistance to therapy, and high risk of transforming into high-grade gliomas (HGGs). Temozolomide (TMZ) is a conventional chemotherapy drug for adjuvant treatment of patients with high-risk LGGs. Na(+)-K(+)-2Cl(-)…